Text Size

Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction

This study has been completed.
Sponsor:
Collaborator:
University of Pittsburgh
Information provided by:
Office of Rare Diseases (ORD)
ClinicalTrials.gov Identifier:
NCT00004366
First received: October 18, 1999
Last updated: June 23, 2005
Last verified: June 2000
History of Changes
  Purpose

OBJECTIVES:

I. Evaluate whether vestibular rehabilitation training is of value in reducing anxiety symptoms in patients with panic disorder with or without agoraphobia who have vestibular dysfunction as identified by clinical vestibular tests.


Condition Intervention
Vestibular Diseases
Agoraphobia
Panic Disorder
 Procedure: Physical therapy

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Primary Purpose: Educational/Counseling/Training

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Office of Rare Diseases (ORD):

Estimated Enrollment: 20
Study Start Date: August 1995
Estimated Study Completion Date: May 2000
Detailed Description:

PROTOCOL OUTLINE: During the first 4 weeks of study, patients meet with a clinical nurse specialist once a week for approximately 1 hour. During this time, the nature of the anxiety disorder is explained and exposure to previously feared situations is encouraged.

Only patients who remain symptomatic at a stable level following self-exposure will proceed with rehabilitation training.

Patients meet with a physical therapist once a week for 4 weeks to further evaluate the extent of problems associated with balance. Then, patients undergo weekly 1 hour exercises for 8 weeks with the physical therapist, focusing on sensation, head and eye coordination, movement with eyes opened and closed, and gait.

Concurrently, patients meet with the clinical nurse specialist every 4 weeks during and after physical therapy to evaluate the effects of vestibular treatment on anxiety symptoms.

Training is continued if patient is symptomatic; otherwise, patient is discharged from study.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • Diagnosed panic disorder with or without agoraphobia
  • Vestibular dysfunction, as defined by abnormalities in the caloric and/or rotational tests
  • Continued symptomatology after general instructions of the importance of exposure to feared situations
  • Absence of acute symptoms of anxiety or depression assessed to need immediate clinical care
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004366

Sponsors and Collaborators
National Center for Research Resources (NCRR)
University of Pittsburgh
Investigators
Study Chair: Rolf G. Jacob University of Pittsburgh
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00004366     History of Changes
Other Study ID Numbers: 199/11944, UPITTS-11760S-950866, 11760S-950866
Study First Received: October 18, 1999
Last Updated: June 23, 2005
Health Authority: United States: Federal Government

Keywords provided by Office of Rare Diseases (ORD):
agoraphobia
anxiety disorder
disease-related problem/condition
neurologic and psychiatric disorders
 panic disorder
rare disease
vestibular diseases

Additional relevant MeSH terms:
Agoraphobia
Panic Disorder
Vestibular Diseases
Anxiety Disorders
 Mental Disorders
Labyrinth Diseases
Ear Diseases
Otorhinolaryngologic Diseases

ClinicalTrials.gov processed this record on May 19, 2013